Consensus GSK plc

Equities

Market Closed - London S.E. Other stock markets 11:35:10 2025-12-05 EST			5-day change	1st Jan Change
1,805.00 ^GBX	-1.15%		+0.78%	+34.05%

12-05	Vaccine makers raise concerns over US panel's shift away from hepatitis B shots for newborns	RE
12-05	Health Rounds: Shingles vaccine reduces risk of death from dementia, study finds	RE

a20d513b40.qR3gC5SQeoBgIH_kJuI-qhcoNkvPU6eaqdTXOyTTFtY.6FSyOfLxFvolDTfQeZZ2k19OYiK4PfKs45OGenuFO4PveZl419s99hZvRw~dcebbe62660f5d8ef5000a74a248f89e

12-04	GSK : UBS sticks Neutral	ZD
12-04	UK stocks rise on boost from industrials and financials	RE
12-02	Janux dives as gaps in prostate cancer study data worry investors	RE
11-28	AnaptysBio, GSK's Tesaro Unit Likely Settle Jemperli Dispute Before July, Wedbush Says	MT
11-25	Berenberg Raises Price Target on GSK to $43 From $41, Keeps Hold Rating	MT
11-25	GSK : Deutsche Bank reiterates its Neutral rating	ZD
11-25	Jefferies cuts Playtech to 'hold'	AN
11-25	Berenberg Updates GSK Estimates as CFO Discusses FY26 Plans; Price Target Up	MT
11-25	GSK : Gets a Neutral rating from Berenberg	ZD
11-24	AnaptysBio Presents Opportunity Despite 'Near-Term Turbulence' Amid Legal Dispute with GSK, Wedbush Says	MT
11-19	GSK : Jefferies keeps its Buy rating	ZD
11-07	America's markets lose their nerve
11-07	Goldman Sachs cuts Weir; UBS ups British Land	AN
11-07	GSK : JP Morgan keeps a Sell rating	ZD
11-05	GSK : Bernstein maintains a Buy rating	ZD
11-04	GSK : Deutsche Bank remains Neutral	ZD
11-04	Shore Capital cuts Next; Bernstein cuts Ryanair	AN
10-31	UBS starts Drax with 'sell'; WPP targets cut	AN
10-31	GSK : Jefferies gives a Buy rating	ZD
10-30	GSK : DZ Bank is Neutral	ZD
10-30	GSK : Deutsche Bank remains Neutral	ZD
10-30	GSK : UBS gives a Neutral rating	ZD
10-30	UBS cuts Ibstock; Deutsche Bank says 'buy' PHP	AN
10-29	FTSE 100 scales new high, powered by strong forecasts from GSK, Next	RE
10-29	GSK PLC : Q3 beat strengthens credibility of GSK's execution skills

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	GSK PLC					+1.55%
	ELI LILLY AND COMPANY					+4.59%
	JOHNSON & JOHNSON					+0.74%
	ABBVIE INC.					+7.73%
	ROCHE HOLDING AG					+0.28%
	ASTRAZENECA PLC					+8.87%
	NOVARTIS AG					-1%
	MERCK & CO., INC.					+6.92%
	NOVO NORDISK A/S					+28.66%
	AMGEN INC.					-1.71%
	Average					+5.66%
	Weighted average by Cap.					+5.20%

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

18.05GBP

Average target price

18.33GBP

Spread / Average Target

+1.55%

High Price Target

25.20GBP

Spread / Highest target

+39.61%

Low Price Target

12.00GBP

Spread / Lowest Target

-33.52%

UBS	Matthew Weston
Berenberg Bank
BERENBERG
JEFFERIES
JPMORGAN	Zain Ebrahim
BERNSTEIN RESEARCH	Justin Smith
DZ BANK	Elmar Kraus
alphavalue	Abhishek Raval
DEUTSCHE BANK RESEARCH	Emmanuel Papadakis
AlphaValue/Baader Europe
Intron Health
Sadif Investment Analytics
GOLDMAN SACHS	Rajan Sharma
BNP Paribas Exane
Jefferies & Co.
Guggenheim
Citigroup
HSBC
LBBW
Bernstein
Barclays
Deutsche Bank Securities
Morgan Stanley
CREDIT SUISSE	Dominic Lunn
Bank of America Securities/Merrill Lynch
Stifel Nicolaus
ODDO BHF
Societe Generale
Liberum Capital
J.P. Morgan Chase
DEUTSCHE BANK	Emmanuel Papadakis
KEPLER CHEUVREUX	David Evans
BAADER BANK
SVB Leerink
BANK OF AMERICA (BOFA)	Graham Parry